Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer. | Mil Med Res | 2023 | 37941075 | PubTator, text mining | PubMed |
| Amplifying mRNA vaccines: potential versatile magicians for oncotherapy. | Front Immunol | 2023 | 37936701 | PubTator, text mining | PubMed |
| Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases. | Front Immunol | 2023 | 37928540 | PubTator, text mining | PubMed |
| Alterations in gut microbiota and host transcriptome of patients with coronary artery disease. | BMC Microbiol | 2023 | 37924005 | PubTator, text mining | PubMed |
| Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study. | Lancet Haematol | 2023 | 37914483 | PubTator, text mining | PubMed |
| Targeting CD70 in acute myeloid leukaemia: an emerging therapeutic angle in combinatorial treatment. | Lancet Haematol | 2023 | 37914475 | PubTator, text mining | PubMed |
| Examining the relationship between inflammatory biomarkers during COVID-19 hospitalization and subsequent long-COVID symptoms: A longitudinal and retrospective study. | Immun Inflamm Dis | 2023 | 37904690 | PubTator, text mining | PubMed |
| Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target. | Nat Cancer | 2023 | 37904046 | PubTator, text mining | PubMed |
| Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis. | Nat Commun | 2023 | 37903821 | PubTator, text mining | PubMed |
| Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma. | Front Immunol | 2023 | 37901209 | PubTator, text mining | PubMed |
| In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future. | Vaccines (Basel) | 2023 | 37897003 | PubTator, text mining | PubMed |
| Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia: A Work in Progress. | Cancers (Basel) | 2023 | 37894427 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies. | Bioengineering (Basel) | 2023 | 37892958 | PubTator, text mining | PubMed |
| Transcriptomic Characterization of Copper-Binding Proteins for Predicting Prognosis in Glioma. | Brain Sci | 2023 | 37891828 | PubTator, text mining | PubMed |
| Regulation of HHLA2 expression in kidney cancer and myeloid cells. | BMC Cancer | 2023 | 37891555 | PubTator, text mining | PubMed |
| Autoantibody Diversity Is Augmented in Women with Breast Cancer and Is Related to the Stage of the Disease. | Curr Oncol | 2023 | 37887534 | PubTator, text mining | PubMed |
| The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment. | Curr Issues Mol Biol | 2023 | 37886952 | PubTator, text mining | PubMed |
| The advances of adjuvants in mRNA vaccines. | NPJ Vaccines | 2023 | 37884526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=23